Transmyocardial revascularization with CO2 laser in patients with refractory angina pectoris
Clinical results from The Norwegian Randomized Trial
Lars Aaberge, MDa,
Kenneth Nordstrand, MD, PhDb,
Morten Dragsund, MDb,
Kjell Saatvedt, MD, PhDb,
Knut Endresen, MD, PhDa,
Svein Golf, MD, PhDb,
Odd Geiran, MD, PhDa,
Michel Abdelnoor, MPH, PhDa and
Kolbjorn Forfang, MD, PhDa
a Division of Heart and Lung Diseases, The National Hospital, University of Oslo, Oslo, Norway
b The Feiring Heart Clinic, Feiring, Norway

View larger version (23K):
[in a new window]
|
Figure 1 Angina symptoms in the transmyocardial revascularization group. Circles with numbers indicate number of patients. Arrows with numbers indicate how many and how patients have changes in symptoms during follow-up.
|
|

View larger version (15K):
[in a new window]
|
Figure 2 Angina symptoms in the medical treatment group. Symbols are as in Figure 1.
|
|
|